IL-4 and IL-13 signaling are essential for recovery from AKI by modulating macrophage polarization from a pro-inflammatory M1 phenotype to the reparative M2 phenotype [35], suggesting that pioglitazone anti-inflammatory activity may stem from its ability to modulate macrophage activity. The gene discussed is IL4; the disease is acute kidney injury.